Non-nutritive Sweeteners in Inflammatory Bowel Disease
Eligible age
18–70 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with IBD, compared to healthy non-IBD individuals. The investigators will focus on studying IBD patients affected with CD as a proof of principle that could be tested later in other IBD subtype (ulcerative colitis or others specific surgical conditions).
Sponsor: University Hospitals Cleveland Medical Center
You may qualify if…
- ✓ Age range from: 18 to 70 years.
- ✓ Male or female.
- ✓ Documented diagnosis of Crohns disease. CD outpatients in remission; Harvey Bradshaw- index in remission (\<6 score).
- ✓ Capable of providing consent to participate.
- ✓ Able to complete daily surveys and take oral nutrition.
- ✓ Able to record meal intake.
- ✓ Healthy controls with no diagnosis of IBD or Irritable Bowel Syndrome (IBS).
You may not qualify if…
- ✕ Short bowel syndrome.
- ✕ Hospitalized patients.
- ✕ Individuals who lack consent capacity, including the mentally ill, prisoners, cognitively impaired participants, dementia patients.
- ✕ Known drug abuse.
- ✕ Known parasitic disease of the digestive system.
- ✕ Symptomatic intestinal stricture/narrowing.
- ✕ Presence of an ostomy.
- ✕ Known active malignancy.
Where it's recruiting
Chagrin Falls · Cleveland · Westlake
Source: ClinicalTrials.gov · NCT07769437 · last updated 2026-09-25